These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4348285)

  • 1. Effect of mineralocorticoid agonists and antagonists on binding of 3 H-aldosterone to adrenalectomized rat kidney plasma membranes.
    Forte LR
    Life Sci I; 1972 May; 11(10):461-73. PubMed ID: 4348285
    [No Abstract]   [Full Text] [Related]  

  • 2. An in vitro study of mineralocorticoid binding proteins from rat kidney.
    Palem-Vliers M; Genard P; Matagne D; Reuter A
    FEBS Lett; 1974 May; 42(1):65-7. PubMed ID: 4368402
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular modifications of anti-aldosterone compounds: effects on affinity of spirolactones for renal aldosterone receptors.
    Funder JW; Feldman D; Highland E; Edelman IS
    Biochem Pharmacol; 1974 May; 23(10):1493-501. PubMed ID: 4367952
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of aldosterone in kidney.
    McDermott M; Latif S; Morris DJ
    J Steroid Biochem; 1983 Aug; 19(2):1205-11. PubMed ID: 6887929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of angiotensin II binding sites in neuronal cultures by mineralocorticoids.
    Sumners C; Fregly MJ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):C121-9. PubMed ID: 2912130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16alpha, 18-Dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats.
    Fuller PJ; Pressley L; Adam WR; Funder JW
    J Steroid Biochem; 1976 May; 7(5):387-90. PubMed ID: 180348
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of adrenal cortical steroids on liver regeneration.
    Gershbein LL
    J Surg Oncol; 1973 May; 5(5):491-508. PubMed ID: 4752467
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of RNA and protein synthesis in the action of aldosterone in the rat.
    Fimognari GM; Fanestil DD; Edelman IS
    Am J Physiol; 1967 Oct; 213(4):954-62. PubMed ID: 6051194
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
    Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
    Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupancy of aldosterone binding sites in rat kidney cytosol.
    Warnock DG; Edelman IS
    Mol Cell Endocrinol; 1978 Nov; 12(2):221-33. PubMed ID: 215476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone and dopamine receptors in the kidney: sites for pharmacologic manipulation of renal function.
    Adam WR
    Kidney Int; 1980 Nov; 18(5):623-35. PubMed ID: 6257964
    [No Abstract]   [Full Text] [Related]  

  • 12. Histone acetylation and hormone action. Early effects of aldosterone on histone acetylation in rat kidney.
    Libby PR
    Biochem J; 1973 Aug; 134(4):907-12. PubMed ID: 4762763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic mineralocorticoid agonist activity of some nonsteroidal anti-inflammatory drugs. A postulated mechanism for sodium retention.
    Feldman D; Couropmitree C
    J Clin Invest; 1976 Jan; 57(1):1-7. PubMed ID: 173739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
    Wenzl HH; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Dig Dis Sci; 1997 Jan; 42(1):119-28. PubMed ID: 9009126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304).
    Marver D; Stewart J; Funder JW; Feldman D; Edelman IS
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1431-5. PubMed ID: 4364539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors.
    Ulmann A; Menard J; Corvol P
    Endocrinology; 1975 Jul; 97(1):46-51. PubMed ID: 166832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex formation by 3 H-aldosterone in rat kidney and liver.
    Morris DJ; Davis RP
    Steroids; 1973 Mar; 21(3):383-96. PubMed ID: 4693732
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates.
    Luzzani F; Glässer A
    Biochem Pharmacol; 1984 Jul; 33(14):2277-81. PubMed ID: 6235813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 19-Oxo-deoxycorticosterone binds to the renal mineralocorticoid receptor and produces sodium retention but not potassium excretion.
    Thomas CJ; Gomez-Sanchez CE; Marver D; Gomez-Sanchez EP
    Endocrinology; 1983 Aug; 113(2):517-22. PubMed ID: 6307643
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of spirolactone action: competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors.
    Fanestil DD
    Biochem Pharmacol; 1968 Oct; 17(10):2240-2. PubMed ID: 5696892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.